Michelle Porte-Garcia
Nurse Practitioner · Fresno, CANPI 1972176345
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 522 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 26.6% of the total. Reporting peaked in 2023 at $3,225 and has fallen 51.1% since, to $1,578 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 522 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$964
- Incyte Corporation$899
- Sanofi$897
- Regeneron Healthcare Solutions, Inc.$695
- Novartis$551
- plus $3K from 19 others
What the payments were for
- Food & beverage$9,72399%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 141 | $2,610 |
| Johnson & Johnson | 86 | $964 |
| Incyte Corporation | 56 | $899 |
| Sanofi | 29 | $897 |
| Regeneron Healthcare Solutions, Inc. | 27 | $695 |
| Novartis | 24 | $551 |
| LEO Pharma Inc. | 14 | $442 |
| Amgen | 20 | $418 |
| Arcutis Biotherapeutics, Inc. | 30 | $410 |
| Sun Pharmaceutical Industries Inc. | 15 | $291 |
| Lilly USA, LLC | 22 | $277 |
| E.r. Squibb & Sons, L.L.C. | 15 | $273 |
| UCB, Inc. | 9 | $210 |
| Janssen Scientific Affairs, LLC | 2 | $210 |
| Dermavant Sciences, Inc. | 3 | $170 |
| Galderma Laboratories, L.p. | 9 | $142 |
| Pfizer | 8 | $129 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $96 |
| Fresenius Kabi USA, LLC | 1 | $27 |
| Kaleo, Inc. | 1 | $20 |
| Optinose US, Inc. | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Biocryst US Sales Co., LLC | 1 | $15 |
| Organon | 1 | $14 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,808 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $41,700 |
| Fluocinonide | 90 | $4,810 |
| Clobetasol Propionate | 45 | $2,743 |
| Metronidazole | 16 | $1,562 |
| Ketoconazole | 74 | $1,256 |
| Desonide | 23 | $866 |
| Betamethasone Dipropionate | 15 | $843 |
| Ciclopirox | 12 | $332 |
| Cephalexin | 12 | $139 |
| Mupirocin | 15 | $65 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fresno
- Erica BedstedFresno$194K
- Sonja GrowcottFresno$31K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.